Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19Gabriella d’Ettorre, Claudio Maria Mastroianni, Giancarlo Ceccarelli et al.|Frontiers in Medicine|2020Cited by 218
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II)Ernesto Maddaloni, Marco Ridolfi, Camilla Ajassa et al.|Cardiovascular Diabetology|2020Cited by 114
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort StudyGiancarlo Ceccarelli, Gabriella d’Ettorre, Cristian Borrazzo et al.|Frontiers in Nutrition|2021Cited by 78
Clinical significance of lymphocytopenia in patients hospitalized with pneumonia caused by influenza virusValeria Bellelli, Mario Venditti, Gabriella d’Ettorre et al.|Critical Care|2019Cited by 44
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort studyBarbara Rossetti, Giordano Madeddu, Gianmaria Baldin et al.|Antiviral Research|2019Cited by 32